Select Page
Rare Disease Stakeholders Demand Regulatory Clarity

Rare Disease Stakeholders Demand Regulatory Clarity

The Food and Drug Administration (FDA) asked for rare disease stakeholders, including individuals and families affected by rare disease(s), pharmaceutical companies, trade associations, and other federal agencies and regulators, to weigh in on a proposed clinical...
FDA Issues EUA for Vela Diagnostics Covid  PCR Test

FDA Issues EUA for Vela Diagnostics Covid PCR Test

The FDA issued yesterday (8/5) Emergency Use Authorization for Vela Diagnostics for the manual version of their Covid PCR test. The manual version of the test enables flexible sample processing, facilitating widespread use of the test throughout the United States. Sam...